HIGHLIGHTS
- who: Yulin Leng from the Hospital of Chengdu University of Traditional Chinese Medicine, No, Shiu2011Eru2011Qiao Road, Chengdu, Sichuan Province, Peopleu2019s Republic of China have published the research: Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial protocol, in the Journal: (JOURNAL) of 10/06/2021
- what: The aim of this trial is to evaluate the efficacy safety and therapeutic mechanism of SQXT formula in the treatment of diabetic peripheral atherosclerosis.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.